by The remote patient monitoring systems market was estimated at US$ 965 million last year and is projected to hit around US$ 5,101 million by 2030, registering a CAGR of 20% between 2022 and 2030. The report contains 180+ pages with detailed analysis.
The global remote patient monitoring systems market is primarily driven by the growing geriatric population across the globe. The old age people are vulnerable to various diseases and needs healthcare support. According to the Unite Nations, there were around 382 million old age people, aged 60 years or above, across the globe in 2017 ad this number is expected 2.1 billion by 2050.
Furthermore, the growing prevalence of various chronic diseases such as cancer, diabetes, and cardiovascular diseases is expected to foster the demand for the remote monitoring systems. The rising incidences of road accidents is propelling the hospital admissions an emergency room visits across the globe, which drive the growth of the remote patient monitoring systems market.
The RPM systems can increase the operational efficiency of the hospitals and can enhance the patient care services. The increasing government investments to develop the healthcare sector by installing latest and advanced technologies is one of the crucial factors that boosts the growth of the global remote patient monitoring systems market. The RPM systems helps in early identification of warning signals an can enhance the health management.
Download a Free Sample Pages (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/sample/1390
Report Scope of the Remote Patient Monitoring Systems Market
| Report Highlights | Details |
| Market Size | USD 5,101 Million by 2030 |
| Growth Rate | CAGR of 20% From 2022 to 2030 |
| Largest Market | North America |
| Fastet Growing Market | Asia Pacific |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Product, Application, End User, Region |
North America dominated the global remote patient monitoring systems market in 2020. The increased consumer awareness regarding the availability of advanced healthcare devices, increased consumer expenditure on healthcare, high disposable income, and developed healthcare infrastructure are the major factors that influences the demand for the RPM systems in the region. Moreover, the increased prevalence of chronic diseases among the population and growing geriatric population in US is the significant contributor to the RPM systems market.
According to a study, around 60% of the US population is suffering from at least one chronic disease. According to the CDC, around 100 million people in US have hypertension, which increases the risk of various heart diseases. Hence, the rising prevalence of various diseases is the major contributor to the market growth in North America.
Asia Pacific is estimated to be the most opportunistic market during the forecast period. Asia Pacific is witnessing increased pollution levels owing to rapid urbanization and rapid industrialization, which is resulting in the rising prevalence of asthma and other respiratory diseases.
Moreover, the presence of huge population, rising disposable income, rising awareness regarding various advanced healthcare technologies, and increased consumer expenditure on the healthcare and the rising government investments to develop the healthcare infrastructure are the major factors that presents a lucrative growth opportunities to the market players.
Read Also: In-Mold Electronics Market is Estimated to Reach USD 2,443.10 Million by 2030
The rapid growth of the telehealth and telemedicine is the major driver of the market. The telehealth and telemedicine includes various devices and software that helps to remotely monitor the patients and it improves the patient care at reduced costs. This factor is expected to drive the growth of the global RPM systems market.
The major threat associated with the new digital technologies is the cybersecurity and data breach that may hamper the growth of the market. The telehealth platforms uses internet and digital devices which makes it vulnerable to cyberattacks.
The introduction of latest technologies like wireless communications and smartphones connectivity is the trending feature in the latest remote patient monitoring systems.
Based on the product, the specialized monitors segment dominated the market, garnering around 81% of the market share in 2020. The specialized monitors efficiently analyzes the clinical data of patient’s health conditions in the pre and post-surgery situation. Technological advancements in the specialized monitors has fueled the demand and is expected to remain dominant segment during the forecast period.
Based on the application, the cardiovascular disease is estimated to be the most opportunistic segment during the forecast period. The rising prevalence of cardiovascular diseases among the global population is projected to drive the growth of this segment. According to the World Health Organization, around 17.9 million deaths were directly linked with the cardiovascular diseases in 2019, globally. Further, the rising prevalence of hypertension, which increases the risk of CVD is also a driving force of the segment.According to the CDC, around 100 million people in US have hypertension, which increases the risk of various heart diseases.
Based on the end use, the hospital patients segment dominated the market, accounting for over 79% of the market share in 2020. The increased incidences of road traffic accidents, increasing number of emergency room visits, and increased penetration of hospitals across the globe are the major drivers of this segment. Moreover, the rising number of private hospitals and ambulatory services is expected to further augment the demand for the RPM systems.
In August 2020, Johnson & Johnson invested in Thirty Madison, a telehealth company to participate in the digital health or e-health industry.In July 2020, Philips and BioIntelliSense collaborated to improve its RPM solutions by integrating the RPM system of BioIntelliSense to its product portfolio. The various developmental strategies like collaborations, acquisitions and mergers fosters market growth and offers lucrative growth opportunities to the market players.
The key players profiled in the global remote patient monitoring systems market are
- Abbott Laboratories
- Aerotel Medical Systems
- AMD Global Telemedicine
- Baxter International Inc.
- Boston Scientific Corporation
- GE Healthcare
- Masimo Corporation
- Medtronic PLC
- F. Hoffmann-La Roche AG
- Omron Corporation
Market Segmentation
By Product
- Specialized Monitors
- Vital Sign Monitors
By Application
- Diabetes
- Cancer
- Cardiovascular Diseases
- Weight Management
- Bronchitis
- Sleep Disorder
- Dehydration
- Virus
- Hypertension
By End Use
- Hospital Patients
- Ambulatory Patients
- Home Healthcare
Regional Segmentation
- North America (U.S. and Canada)
- Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
- Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
- Latin America (Brazil and Rest of Latin America)
- Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)
TABLE OF CONTENT
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Remote Patient Monitoring Systems Market
5.1. COVID-19 Landscape: Remote Patient Monitoring Systems Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Remote Patient Monitoring Systems Market, By Product
8.1. Remote Patient Monitoring Systems Market, by Product Type, 2021-2030
8.1.1. Specialized Monitors
8.1.1.1. Market Revenue and Forecast (2019-2030)
8.1.2. Vital Sign Monitors
8.1.2.1. Market Revenue and Forecast (2019-2030)
Chapter 9. Global Remote Patient Monitoring Systems Market, By Application
9.1. Remote Patient Monitoring Systems Market, by Application, 2021-2030
9.1.1. Diabetes
9.1.1.1. Market Revenue and Forecast (2019-2030)
9.1.2. Cancer
9.1.2.1. Market Revenue and Forecast (2019-2030)
9.1.3. Cardiovascular Diseases
9.1.3.1. Market Revenue and Forecast (2019-2030)
9.1.4. Weight Management
9.1.4.1. Market Revenue and Forecast (2019-2030)
9.1.5. Bronchitis
9.1.5.1. Market Revenue and Forecast (2019-2030)
9.1.6. Sleep Disorder
9.1.6.1. Market Revenue and Forecast (2019-2030)
9.1.7. Dehydration
9.1.7.1. Market Revenue and Forecast (2019-2030)
9.1.8. Virus
9.1.8.1. Market Revenue and Forecast (2019-2030)
9.1.9. Hypertension
9.1.9.1. Market Revenue and Forecast (2019-2030)
Chapter 10. Global Remote Patient Monitoring Systems Market, By End Use
10.1. Remote Patient Monitoring Systems Market, by End Use, 2021-2030
10.1.1. Hospital Patients
10.1.1.1. Market Revenue and Forecast (2019-2030)
10.1.2. Ambulatory Patients
10.1.2.1. Market Revenue and Forecast (2019-2030)
10.1.3. Home Healthcare
10.1.3.1. Market Revenue and Forecast (2019-2030)
Chapter 11. Global Remote Patient Monitoring Systems Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.3. Market Revenue and Forecast, by End Use (2019-2030)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.4.3. Market Revenue and Forecast, by End Use (2019-2030)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.1.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.1.5.3. Market Revenue and Forecast, by End Use (2019-2030)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.3. Market Revenue and Forecast, by End Use (2019-2030)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.4.3. Market Revenue and Forecast, by End Use (2019-2030)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.5.3. Market Revenue and Forecast, by End Use (2019-2030)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.6.3. Market Revenue and Forecast, by End Use (2019-2030)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.2.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.2.7.3. Market Revenue and Forecast, by End Use (2019-2030)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.3. Market Revenue and Forecast, by End Use (2019-2030)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.4.3. Market Revenue and Forecast, by End Use (2019-2030)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.5.3. Market Revenue and Forecast, by End Use (2019-2030)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.6.3. Market Revenue and Forecast, by End Use (2019-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.3.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.3.7.3. Market Revenue and Forecast, by End Use (2019-2030)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.3. Market Revenue and Forecast, by End Use (2019-2030)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.4.3. Market Revenue and Forecast, by End Use (2019-2030)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.5.3. Market Revenue and Forecast, by End Use (2019-2030)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.6.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.6.3. Market Revenue and Forecast, by End Use (2019-2030)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Product (2019-2030)
11.4.7.2. Market Revenue and Forecast, by Application (2019-2030)
11.4.7.3. Market Revenue and Forecast, by End Use (2019-2030)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.3. Market Revenue and Forecast, by End Use (2019-2030)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.4.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.4.3. Market Revenue and Forecast, by End Use (2019-2030)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Product (2019-2030)
11.5.5.2. Market Revenue and Forecast, by Application (2019-2030)
11.5.5.3. Market Revenue and Forecast, by End Use (2019-2030)
Chapter 12. Company Profiles
12.1. Abbott Laboratories
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Aerotel Medical Systems
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. AMD Global Telemedicine
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Baxter International Inc.
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Boston Scientific Corporation
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. GE Healthcare
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Masimo Corporation
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Medtronic PLC
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. F. Hoffmann-La Roche AG
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Omron Corporation
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
Thanks for reading you can also get individual chapter-wise sections or region-wise report versions such as North America, Europe, or the Asia Pacific.
Buy this Premium Research Report@https://www.precedenceresearch.com/checkout/1390
